Product Innovations Will Drive Global Endometrial Ablation Device Sales in the US Over the Next Five Years

TORONTO, Nov. 30, 2010 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the global endometrial ablation market is the largest segment in the US gynecological device market.  New devices, along with an acquisition and a new strategic partnership in the industry, will drive market growth over the next five years.

In May 2010, Boston Scientific released its new product, the Genesys HTA System.  The product is equipped with a new Seal Integrity Check to assist in a proper cervical seal, along with a full color LCD screen allowing for clearer imaging during the procedure.  The free flowing hot fluid is capable of reaching difficult areas even with the presence of fibroids. Hologic also released its next-generation NovaSure system in May 2010. NovaSure is a bipolar desiccation device used specifically for quick and convenient ablation. The device has a three-dimensional gold-plated bipolar mesh electrode on the end that expands until it meets the walls of the uterine cavity. The walls of the cavity are kept in contact with the radiofrequency mesh with suction. Radiofrequency energy, calculated from the uterine size, is channeled through the mesh balloon, ablating the endometrium.  The uptake of these innovative products will fuel market expansion over the next five years.

Acquisitions and strategic partnerships will also drive market growth. In February 2010, Cooper Surgical acquired American Medical Systems' Her Option. In November 2010, Conceptus announced that it will begin promoting Ethicon Women's Health & Urology's global endometrial ablation product, Thermachoice. As leading competitors in the female sterilization market, Cooper Surgical and Conceptus will look to leverage existing relationships with gynecologists' offices to drive sales in the growing global endometrial ablation market.  

"Patient preference for minimally invasive gynecological procedures performed in physicians' offices will be a growing trend in this market," says Norman Yeung, Analyst at MRG. "Companies are therefore focused on expanding global endometrial ablation device sales network into this setting."

MRG's US Markets for Gynecological Devices 2011 report provides critical insight into trends that will fuel and limit market growth for gynecological devices in the US, with coverage of global endometrial ablation, female sterilization, assisted reproductive consumables, uterine artery embolization, hysteroscopes, colposcopes, fluid management, and endometrial resection devices. The report includes a breakdown of procedures in addition to unit volumes, average selling prices, market values, and market shares in each market segment.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer behavior tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

SOURCE Millennium Research Group

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED